A detailed history of M3 Advisory Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, M3 Advisory Group, LLC holds 2,513 shares of ABBV stock, worth $486,290. This represents 0.35% of its overall portfolio holdings.

Number of Shares
2,513
Previous 2,422 3.76%
Holding current value
$486,290
Previous $441 Million 2.29%
% of portfolio
0.35%
Previous 0.4%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$154.79 - $180.76 $14,085 - $16,449
91 Added 3.76%
2,513 $431 Million
Q1 2024

Apr 29, 2024

BUY
$159.82 - $182.1 $19,977 - $22,762
125 Added 5.44%
2,422 $441 Million
Q4 2023

Mar 19, 2024

BUY
$137.6 - $154.97 $316,067 - $355,966
2,297 New
2,297 $356 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track M3 Advisory Group, LLC Portfolio

Follow M3 Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M3 Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on M3 Advisory Group, LLC with notifications on news.